Aptevo Therapeutics Inc. (APVO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.29
Day's range
$6.74

Aptevo Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GSA CAPITAL PARTNERS LLP 05/08/2026 19.64 K $84.00 K   100.00% 1.85%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 13.34 K $56.95 K   100.00% 1.26%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 12.71 K $54.29 K   100.00% 1.20%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 4.14 K $17.69 K   100.00% 0.39%
UBS GROUP AG 05/05/2026 3.45 K $14.71 K   1,926.47% 0.32%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 360 $1.54 K   0.00% 0.03%
SBI SECURITIES CO., LTD. 04/28/2026 109 $465   251.61% 0.01%
CWM, LLC 05/14/2026 5 $21   100.00% 0.00%
DANSKE BANK A/S 05/12/2026 1 $4   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
FMR LLC 05/15/2026 0 $0   -100.00% 0.00%
CITIGROUP INC 05/11/2026 0 $0   -100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 0 $0   -100.00% 0.00%
TRADEWINDS CAPITAL MANAGEMENT, LLC 04/15/2026 0 $0   -100.00% 0.00%

Aptevo Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 5 institutional investors and hedge funds held shares of Aptevo Therapeutics Inc. The most heavily invested institutionals were:

CWM, LLC: 5

VANGUARD GROUP INC: 16,856

CLEAR STREET LLC: 0

BlackRock Inc.: 888

QS Investors, LLC: 15,650

5.07% of Aptevo Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 33.40 K shares in the last 24 months. This purchase volume represents approximately $220.43 K in transactions.